Business Description
NGeneBio Co Ltd
ISIN : KR7354200008
Share Class Description:
XKRX:354200: Ordinary SharesCompare
Compare
Traded in other countries / regions
354200.Korea IPO Date
2020-12-10Description
NGeneBio Co Ltd is engaged in the business of developing companion diagnosis, disease diagnosis, and liquid biopsy products and bioinformatics software.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.44 | |||||
| Equity-to-Asset | 0.26 | |||||
| Debt-to-Equity | 1.51 | |||||
| Debt-to-EBITDA | -1.67 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -2.92 | |||||
| Beneish M-Score | -0.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.6 | |||||
| 3-Year EBITDA Growth Rate | 1.4 | |||||
| 3-Year EPS without NRI Growth Rate | -6.1 | |||||
| 3-Year FCF Growth Rate | -5.3 | |||||
| 3-Year Book Growth Rate | -28 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.82 | |||||
| 9-Day RSI | 30.47 | |||||
| 14-Day RSI | 32.82 | |||||
| 6-1 Month Momentum % | -2.16 | |||||
| 12-1 Month Momentum % | -49.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.57 | |||||
| Quick Ratio | 0.48 | |||||
| Cash Ratio | 0.27 | |||||
| Days Inventory | 207.18 | |||||
| Days Sales Outstanding | 65.06 | |||||
| Days Payable | 15.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.8 | |||||
| Shareholder Yield % | -3.21 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.9 | |||||
| Operating Margin % | -235.89 | |||||
| Net Margin % | -170.46 | |||||
| FCF Margin % | -241.3 | |||||
| ROE % | -80.58 | |||||
| ROA % | -26.59 | |||||
| ROIC % | -34.86 | |||||
| ROC (Joel Greenblatt) % | -93.87 | |||||
| ROCE % | -62.47 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.03 | |||||
| PB Ratio | 2.87 | |||||
| Price-to-Tangible-Book | 16.26 | |||||
| EV-to-EBIT | -4.15 | |||||
| EV-to-EBITDA | -5.37 | |||||
| EV-to-Revenue | 6.83 | |||||
| EV-to-FCF | -2.83 | |||||
| Earnings Yield (Greenblatt) % | -24.1 | |||||
| FCF Yield % | -44.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NGeneBio Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 6,176.426 | ||
| EPS (TTM) (â‚©) | -720.274 | ||
| Beta | -0.53 | ||
| Volatility % | 71.64 | ||
| 14-Day RSI | 32.82 | ||
| 14-Day ATR (â‚©) | 170.62385 | ||
| 20-Day SMA (â‚©) | 2069.15 | ||
| 12-1 Month Momentum % | -49.46 | ||
| 52-Week Range (â‚©) | 1558 - 6520.555006 | ||
| Shares Outstanding (Mil) | 19.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NGeneBio Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NGeneBio Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
NGeneBio Co Ltd Frequently Asked Questions
What is NGeneBio Co Ltd(XKRX:354200)'s stock price today?
The current price of XKRX:354200 is â‚©1713.00. The 52 week high of XKRX:354200 is â‚©6520.56 and 52 week low is â‚©1558.00.
When is next earnings date of NGeneBio Co Ltd(XKRX:354200)?
The next earnings date of NGeneBio Co Ltd(XKRX:354200) is .
Does NGeneBio Co Ltd(XKRX:354200) pay dividends? If so, how much?
NGeneBio Co Ltd(XKRX:354200) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers